INMED PHARMACEUTICALS INC. (INM) Return on equity 2021–2025
INMED PHARMACEUTICALS INC. (INM) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-60.8%FY2025 · since FY2021: -138.3% → -60.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -60.8% | +22.6 pp |
| FY2024 | -83.4% | -17.6 pp |
| FY2023 | -65.7% | +139.1 pp |
| FY2022 | -204.9% | -66.6 pp |
| FY2021 | -138.3% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice